A CME Symposium during the 2026 Annual Meeting for the American Association of Heart Failure Nurses in San Diego, California.

AGENDA

4:35 pm          Introduction

                        Nancy Albert, PhD, CCNS, CHFN, CCRN, NE-BC

4:38 pm          Hyperkalemia: A Barrier to Optimization of HF Treatment

                        Nancy Albert, PhD, CCNS, CHFN, CCRN, NE-BC

4:53 pm          Overcoming the Barrier of Hyperkalemia: Treatment with Potassium Binders and Maintaining RAAS Inhibitor Therapy in HF Patients

                        Stephen Greene, MD

5:08 pm          Evidence-Based Practice: Managing the Patient with Elevated Potassium

                        Case Presenter: Stephanie Barnes, DNP, AGNP-C, CHFN

                        Panelists: Nancy Albert, PhD, CCNS, CHFN, CCRN, NE-BC; Stephen Greene, MD

5:23 pm          Question and Answer

EDUCATIONAL OBJECTIVES

• Recognize the relationship of hyperkalemia (or fear of hyperkalemia) and underuse and underdosing of RAASis in HF

• Explain the relationship between down-titration or discontinuation of RAASis and clinical outcomes

• Explain the key characteristics of, and clinical evidence with novel potassium binders

• Identify HF patients who would benefit from novel potassium binders for the treatment of hyperkalemia

Educational Grant

AAHFN and Voxmedia International gratefully acknowledge the educational grant provided by AstraZeneca Pharmaceuticals.

CHAIR

Nancy Albert, PhD, CCNS, CHFN, CCRN, NE-BC

Associate Chief Nursing Officer--Research and Innovation

Clinical Nurse Specialist--Kaufman Center for Heart Failure

Cleveland Clinic

Cleveland, Ohio

FACULTY

Stephanie Barnes, DNP, AGNP-C, CHFN

Clinical Director for Advanced Heart Failure

Duke University Health System

Durham, North Carolina

Stephen Greene, MD

Associate Professor of Medicine

Duke University School of Medicine

Duke Clinical Research Institute

Durham, North Carolina